HIGHLIGHTS
- who: Yuqi Huang and collaborators from the Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University have published the research work: TPX2 Is a Prognostic Marker and Contributes to Growth and Metastasis of Human Hepatocellular Carcinoma, in the Journal: (JOURNAL)
- what: The authors demonstrate that elevated expression of TPX2 is observed in the HCC tissues and cells. The authors demonstrate that the positive expression of TPX2 confers a worse 5-year survival rate of HCC patients after surgery.
- how: The data indicated that the expression levels of TPX2 in HCC were significantly higher . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.